View the Latest: Chronic Diseases
Filter
-
-
The $174 Billion Question: How to Reduce Diabetes and Obesity
Event Date:EventDiabetes and obesity have evolved from a national public health concern to a problem of epidemic proportions — a very costly problem. The direct medical costs and the indirect costs of diabetes are estimated at $174 billion yearly.
-
Prevalence of Selected Chronic Conditions Among Men, by Race and Ethnicity, 2006-2008
FeaturePrevalence of Selected Chronic Conditions Among Men, by Race and Ethnicity, 2006-2008 Download Source Kaiser Family Foundation, Putting Men’s Health Care Disparities on the Map, Examining Racial and Ethnic Disparities at the State Level, 2012.
-
How is the Affordable Care Act Leading to Changes in Medicaid Today? State Responses to Five New Options
Issue BriefThis policy brief examines how states in every region have responded to five key opportunities available under the health reform law to help them prepare for the significant expansion of Medicaid in 2014.
-
Medicaid’s New “Health Home” Option
Issue BriefThis brief provides key information about the new option for state Medicaid programs to provide "health home" services for enrollees with chronic conditions. The option, established under the new health reform law, took effect on Jan. 1, 2011.
-
Chronic Disease and Co-Morbidity Among Dual Eligibles: Implications for Patterns of Medicaid and Medicare Service Use and Spending
ReportThe health reform law contains provisions that aim to improve the delivery and coordination of services for persons enrolled in both Medicaid and Medicare, known as the dual eligibles. This population includes individuals with some of the most severely disabling chronic conditions.
-
Health Affairs Article: Medicaid Expansion Under Health Reform May Increase Service Use and Improve Access For Low-Income Adults With Diabetes
Issue BriefThis analysis finds that Medicaid’s role in financing diabetes care will grow when many low-income uninsured people with diabetes become eligible for Medicaid as the program expansions under the Affordable Care Act in 2014.
-
A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity
Issue BriefThe FDA recently approved a new use for Wegovy, the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese - a decision that opens the door to Medicare coverage of Wegovy, which is prohibited by law from covering drugs used for obesity. This brief analyses how many Medicare beneficiaries could be eligible for the new use of Wegovy and the potential impact on Medicare spending.
-
New KFF/Los Angeles Times Survey Highlights the Financial Challenges Facing People with Employer Health Benefits
News ReleaseA new KFF/Los Angeles Times survey of Americans with employer health benefits finds that although most are largely satisfied with their employer plan, many report financial challenges related to their health care costs, particularly among those facing high deductibles or suffering from chronic health conditions.
-
How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?
Issue BriefPrescription drug costs are a pressing concern for both consumers and policymakers. This analysis compares prescription drug spending and use in large private employer plans, Medicare Part D, and Medicaid, based primarily on claims data by payer, which does not account for rebates.